July 2022 Drug Utilization Review Board Meeting Summary

The Texas Drug Utilization Review Board met Friday, July 22, to make recommendations about clinical prior authorizations and drugs on the Texas Medicaid Preferred Drug List. A summary of the meeting is now available.

Other news

Hepatitis C Treatment Coverage and PDL Update Scheduled for September 1
Clinical Prior Authorization for Xenical No Longer Required After September 12
Clinical Prior Authorization Assistance Chart Now Available

You have subscribed to get updates about Texas Health and Human Services (HHS). For more information about HHS, please visit our website.

Stay Connected
					(en español)

Subscriber Services
Manage Preferences | Unsubscribe | Help


This email was sent to [email protected] using govDelivery Communications Cloud on behalf of: Texas Health and Human Services Commission · 707 17th St, Suite 4000 · Denver, CO 80202